aeon astron corporation...aeon astron europe b.v.: reference list, version 46, january 2017 2...
TRANSCRIPT
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 1
Aeon Astron Europe B.V.
Publication list
= highlight article.
(A). Publications (2008-present: 42 SCI/SCIE publications)
Biocornea
1. Van Essen TH, van Zijl L, Possemiers T, et al. Biocompatibility of a fish
scale-derived artificial cornea: Cytotoxicity, cellular adhesion and
phenotype, and in vivo immunogenicity. Biomaterials. 2016;81:36-45.
(SCI/SCIE)
2. Chen SC, Telinius N, Lin HT, et al. Use of fish scale-derived BioCornea to
seal full-thickness corneal perforations in pig models. PLoS One.
2015;10(11):e0143511. (SCI/SCIE)
3. Hos D, van Essen TH, Bock F, et al. [Decellularized collagen matrix from
tilapia fish scales for corneal reconstruction (BioCornea)]. Ophthalmologe.
2014;111(11):1027-1032. (SCI/SCIE)
4. Yuan F, Wang L, Lin CC, Chou CH, Li L. A cornea substitute derived from
fish scale: 6-month followup on rabbit model. J Ophthalmol.
2014:914542.
5. Van Essen TH, Lin CC, Hussain AK, et al. A fish scale-derived collagen
matrix as artificial cornea in rats: Properties and potential. Investig
Ophthalmol Vis Sci. 2013;54(5):3224-3233. doi:10.1167/iovs.13-11799.
(SCI/SCIE)
6. Van Essen T, Lin C, Lai H, Hussain A, Luyten G, Jager M. A biocornea of fish
scales - First results of a research model. Acta Ophthalmol.
2011;89(s246):0-0.
7. Van Essen, T. et al. A biocornea of fish scales - First results of a research
model. Acta Ophthalmol. 89, (2011). (SCI/SCIE)
8. Lin, C. C. et al. A new fish scale-derived scaffold for corneal regeneration.
Eur. Cells Mater. 19, 50–57 (2010). (SCI/SCIE)
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 2
Biobone
1. Chou C-H, Chen Y-G, Lin C-C, Lin S-M, Yang K-C, Chang S-H. Bioabsorbable
fish scale for the internal fixation of fracture: a preliminary study. Tissue
Eng Part A. 2014;20(17-18):2493-2502. (SCI/SCIE)
ologen® Collagen Matrix
1. El-Sayyad F, El-Saied HMA, Abdelhakim MASE. Trabeculectomy with
Ologen versus Mitomycin C in Juvenile Open-Angle Glaucoma: A 1-Year
Study. Ophthalmic Res. 2017. doi:10.1159/000456719. (SCI/SCIE)
2. Tanna AP, Rademaker AW, de Moraes CG, et al. Collagen matrix vs
mitomycin-C in trabeculectomy and combined phacoemulsification and
trabeculectomy: a randomized controlled trial. BMC Ophthalmol.
2016;16(1):217. (SCI/SCIE)
3. Fan KC, Guan H, Chaku M, Eliassi-rad B, Desai MA. Ologen versus
Mitomycin-C for Trabeculectomy in a Predominantly African American
Population. Glaucoma Open Access. 2016;1(1 :104):1-6.
4. Elhefney EM, Al-Sharkawy HT, Kishk HM, Abouelkheir H. Safety and efficacy
of collagen matrix implantation in infantile glaucoma. Eur J Ophthalmol.
2016;7:0. (SCI/SCIE)
5. Park KH, Kim JY, Choo SW, Yoon HY, Jeong SW. Ahmed glaucoma valve
implantation with Ologen Collagen Matrix for the surgical treatment of
feline glaucoma. Vet Ophthalmol. 2016:1-5. (SCI/SCIE)
6. Perez CI, Mellado F, Jones A, Colvin R. Trabeculectomy Combined With
Collagen Matrix Implant (Ologen). J Glaucoma. 2016;00(00):1. (SCI/SCIE)
7. Elmallah MH, Mohamed T, Elmahdy A. A comparative study between
trabeculotomy with deroofing of Schlemm’s canal augmented with Ologen
implant and conventional trabeculotomy in primary congenital glaucoma.
Delta J Ophthalmol. 2016;17:24-28.
8. Angmo D, Wadhwani M, Upadhyay AD, Temkar S, Dada T. Outcomes of
Trabeculectomy Augmented With Subconjunctival and Subscleral Ologen
Implantation in Primary Advanced Glaucoma. J Glaucoma. 2016;00(00):1.
(SCI/SCIE)
9. Stephens JD, Sarkisian, Jr. SR. The use of collagen matrix (Ologen) as a
patch graft in glaucoma tube shunt surgery, a retrospective chart review.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 3
F1000Research. 2016;5:1898.
10. El-Saied H, Abdelhakim M. Trabeculectomy with ologen in secondary
glaucomas following failed trabeculectomy with MMC: comparative study.
Eye. 2016:1-9. (SCI/SCIE)
11. Dada T, Sharma R, Sinha G, Angmo D, Temkar S. Cyclodialysis-enhanced
trabeculectomy with triple Ologen implantation. Eur J Ophthalmol.
2016;26(1):95-97. (SCI/SCIE)
12. Cillino S, Casuccio A, Di Pace F, Cagini C, Ferraro LL, Cillino G.
Biodegradable collagen matrix implant versus mitomycin-C in
trabeculectomy: five-year follow-up. BMC Ophthalmol. 2016;16(1):24.
(SCI/SCIE)
13. 罗丹, 温跃春, 季青山. 小梁切除术分别联合Ologen植入与丝裂霉素C治疗青光眼的
有效性和安全性对比分析. 眼科新进展. 2016;36(2):175-177.
14. Wang X, Khan R, Coleman A. Device-modified trabeculectomy for glaucoma.
Cochrane Database Syst Rev. 2016;(12):583-592.
15. Menda SA, Lowry EA, Porco TC, Stamper RL, Rubin MR, Han Y. Ex-PRESS
outcomes using mitomycin-C, Ologen alone, Ologen with 5-fluorouracil. Int
Ophthalmol. 2015;35(3):357-363. (SCI/SCIE)
16. Cho C-H, Lee S-B. Biodegradable collagen matrix (OlogenTM) implant and
conjunctival autograft for scleral necrosis after pterygium excision: two
case reports. BMC Ophthalmol. 2015;15:140. (SCI/SCIE)
17. Rho S, Sung Y, Ma KT, Rho SH, Kim CY. Bleb analysis and short-term results
of biodegradable collagen matrix-augmented ahmed glaucoma valve
implantation: 6-month follow-up. Investig Ophthalmol Vis Sci.
2015;56(10):5896-5903.
18. Hafez M. Trabeculectomy with collagen matrix implantation versus
trabeculectomy with mitomycin C application for the treatment of primary
congenital glaucoma. J Egypt Ophthalmol Soc. 2015;108(2):26.
19. Gasanova NA. Pediatric glaucoma profile in Azerbaijan. Ophthalmol Russ.
2015;12(1):39-44.
20. Yuan F, Li L, Chen X, Yan X, Wang L. Biodegradable 3D-Porous Collagen
Matrix (Ologen) Compared with Mitomycin C for Treatment of Primary
Open-Angle Glaucoma: Results at 5 Years. J Ophthalmol. 2015. (SCI/SCIE)
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 4
21. Sorkhabi R, Fard AM, Poursayed Z, Veshagh M. Evaluating the Results of
Trabeculectomy with Collagen Matrix Compared with Mitomycin C and
Trabeculectomy without Adjuvant in Patients with Open-Angle Glaucoma.
Paripex-Indian J Res. 2015;4(5):22-26.
22. Jung JW, Kwon KY, Choi DL, Kim T-I, Kim EK, Seo KY. Long-term clinical
outcomes of conjunctival flap surgery for calcified scleromalacia after
periocular surgery. Cornea. 2015;34(3):308-312.
23. Hamdi M, Hamdi I. Scleral Repair by Biodegradable Collagen Implant in
Strabismus Surgery. Ophthalmol Res An Int J. 2015;3(4):141-146.
24. Ji Q, Qi B, Liu L, Guo X, Zhong J. Efficacy and Safety of Ologen Implant
Versus Mitomycin C in Primary Trabeculectomy: A Meta-analysis of
Randomized Clinical Trials. J Glaucoma. 2015;24(5):e88-e94. (SCI/SCIE)
25. Niu W, Shen G, Yuan Y, et al. Biodegradable PTLGA Terpolymers versus
Collagen Implants Used as an Adjuvant in Trabeculectomy in Rabbit Eye. J
Ophthalmol. 2015;2015:1-9. (SCI/SCIE)
26. Tiwari S, B NVK, Shukla R, Pardhi P. Ologen and Pharmaceutical Elements
as Adjuvants in Trabeculectomy - Techniques and Results. Glaucoma - II
Free Pap. 2015:385-388.
27. Hamdi MM, Hamdi IM. Collagen Matrix Implant (Ologen)TM in Glaucoma
Surgeries; Precautions for a Better Control of Intraocular Pressure.
Ophthalmol Res An Int J. 2015;4(1):16-24.
28. Toh ZH, Lee CSY, Chew ACY, Perera S. Time Heals All Wounds: Obstacles in
Glaucoma Surgery from an Asian Perspective. Proc Singapore Healthc.
2015;24(2):103-112. (SCI/SCIE)
29. Voykov B, Rohrbach JM. Histopathological findings of a one-month old
Ologen implant. Clin Experiment Ophthalmol. 2015;43(6):604-605.
(SCI/SCIE)
30. Ichhpujani P, Dada T, Bhartiya S. Biodegradable Collagen Implants in
Trabeculectomy. J Curr Glaucoma Pr. 2015;9(1):24-27.
31. Rosentreter A, Gaki S, Cursiefen C, Dietlein TS. Trabeculectomy using
mitomycin C versus an atelocollagen implant: Clinical results of a
randomized trial and histopathologic findings. Ophthalmologica.
2014;231(3):133-140. doi:10.1159/000356400. (SCI/SCIE)
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 5
32. Gupta S, Wadhwani M, Sehgal V, Sharma S, Dada T. Blebitis with scleral
abscess in a case of operated trabeculectomy with mitomycin C and a
subcunjunctival ologen implant. Eye. 2014;28(3):354. (SCI/SCIE)
33. El-Malah MA, Shelil AE, GamalTahoon, Saleh MA, Galhoom AI, Ziada AGEHE
din A. A prospective comparative study between trabeculectomy alone
versus trabeculectomy with Ologen for patients with open angle glaucoma
two years follows up. Mohamed. J Am Sci. 2014;10(11):109-113.
34. 陈秀萍, 董春琼, 袁非. 翼状胬肉切除联合 ologen 植入术后三年随访。 中華全科醫
師雜誌. 2014;13(09):796-797.
35. Arish M. Nadjafi AN. Jahangard M. Collagen matrix implantation
following pterygium excision: outcomes of a preliminary tested hypothesis.
Med Hypothesis Discov Innov Ophthalmol. 2013;2(4):102-104.
36. Radhakrishnan OK, Pahuja K, Patel K, Chandna S. OLOGEN implant in the
management of glaucoma in an unusual case of Axenfeld-Rieger syndrome.
Oman J Ophthalmol. 2014;7(2):90-92.
37. He M, Wang W, Zhang X, Huang W. Ologen implant versus mitomycin C for
trabeculectomy: A systematic review and meta-analysis. PLoS One.
2014;9(1):1-9.doi:10.1371/journal.pone.0085782. (SCI/SCIE)
38. Johnson MS, Sarkisian SR. Using a Collagen Matrix Implant (Ologen) Versus
Mitomycin-C as a Wound Healing Modulator in Trabeculectomy With the
Ex-PRESS Mini Glaucoma Device: A 12-Month Retrospective Review. J
Glaucoma. 2013;23:649-652. (SCI/SCIE)
39. Dietlein TS, Lappas A, Rosentreter A. Secondary subconjunctival
implantation of a biodegradable collagen-glycosaminoglycan matrix to
treat ocular hypotony following trabeculectomy with mitomycin C. Br J
Ophthalmol. 2013;97(8). (SCI/SCIE)
40. Hamdi M. Trabeculectomy assisted by collagen matrix implant (Ologen) in
primary congenital glaucoma. J Egypt Ophthalmol Soc. 2013;106(3):
188-193. doi:10.4103/2090-0686.127398.
41. Tanuj D, Amit S, Saptorshi M, Meenakshi G. Combined subconjunctival and
subscleral ologen implant insertion in trabeculectomy. Eye.
2013;27(7):889. (SCI/SCIE)
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 6
42. Anguelov B. Ex-PRESS® and OlogenTM - single step implantation of two
implants with a different mechanism of action in glaucoma surgery. Bulg
Forum “Glaucoma.” 2013;3(5):224-239.
43. Anguelov B. Clinical cases of surgical revision with OlogenTM implantation
in eyes with glaucoma and Еx-PRESS¨ implant. Bulg Forum “Glaucoma.”
2013;3(4):173-182.
44. Senthil S, Rao HL, Babu JG, Mandal AK, Garudadri CS. Comparison of
outcomes of trabeculectomy with mitomycin C vs. ologen implant in
primary glaucoma. Indian J Ophthalmol. 2013;61(7):338-342. (SCI/SCIE)
45. Razeghinejad MR, Fudemberg SJ, Spaeth GL. The changing conceptual
basis of trabeculectomy: A review of past and current surgical techniques.
Surv Ophthalmol. 2012;57(1):1-25. (SCI/SCIE)
46. Oana S, Vila J. Tube exposure repair. J Curr Glaucoma Pract.
2012;6(3):139-142.
47. Narayanaswamy A, Perera SA, Htoon HM, et al. Efficacy and safety of
collagen matrix implants in phacotrabeculectomy and comparison with
mitomycin C augmented phacotrabeculectomy at 1 year. Clin Exp
Ophthalmol. 2013;41(6):552-560. (SCI/SCIE)
48. Min JK, Kee CW, Sohn SW, Lee HJ, Woo JM, Yim JH. Surgical outcome of
mitomycin C-soaked collagen matrix implant in trabeculectomy. J
Glaucoma. 2013;22(6):456-462. (SCI/SCIE)
49. Marey HM, Mandour SS, Ellakwa AF. Subscleral trabeculectomy with
mitomycin-C versus ologen for treatment of glaucoma. J Ocul Pharmacol
Ther. 2013;29(3):330-334. (SCI/SCIE)
50. Dada T, Kusumesh R, Bali SJ, et al. Trabeculectomy With Combined Use of
Subconjunctival Collagen Implant and Low-dose Mitomycin C. J Glaucoma.
2012;22(8):1. (SCI/SCIE)
51. Anguelov B. Surgical treatment of some types of advanced glaucoma with a
single step implantation of two different implants - Ex-PRESS¨ and
OlogenTM. Bulg Forum “Glaucoma.” 2012;2(4):04-17.
52. Kohlhaas M. Trabekulektomie mit Mitomycin C und Ologen.
Ophthalmo-Chirurgie. 2012;24(1):19.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 7
53. Kasimov EM, Aghayeva FA. First results of the implantation of OlogenTM
collagen matrix in primary trabeculectomy. J Ophthalmol Azerbaijan.
2012;2(9):34-38.
54. De Peron R. The use of ologen collagen implant in traditional
trabeculectomy. Trib Medica Ticin. 2012;77:355-359.
55. Lee SJ, Woo JM, Min JK, Kee CW, Yim JH. The Analysis of The Clinical
Findings And Effects of Biodegradable Collagen Matrix in Trabeculectomy. J
Korean Ophthalmol Soc. 2012;53(2):297-305.
56. Cillino S, Di Pace F, Cillino G, Casuccio a. Biodegradable collagen matrix
implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month,
randomized clinical trial. Eye. 2011;25(12):1598-1606. (SCI/SCIE)
57. Nilforushan N, Yadegari M, Hodjat P. Comparison of the success rate of
trabeculectomy with Oculusgen versus trabeculectomy with mitomycin C.
Iran J Ophthalmol. 2011;23(4):03-12.
58. Sarkisian SR, Rouse JM. New methods and modifications of glaucoma
filtration surgery. Int Ophthalmol Clin. 2011;51(3):95-106.
59. Rosentreter A, Schild AM, Dinslage S, Dietlein TS. Biodegradable implant
for tissue repair after glaucoma drainage device surgery. J Glaucoma.
2012;21(2):76-78. (SCI/SCIE)
60. 申家泉 , 王聪 . 新生血管性青光眼研究进展 . 山东大学耳鼻喉眼学报 .
2011;25(5):92-94.
61. Tendulkar M, Jacobs NA, Ghosh YK. Modified trabeculectomy technique
called effective , quick , reproducible. Ocular Surgery News. 2011.
62. Radcliffe NM. Evolutions and Revolutions in Surgical Energy. Glaucoma
Today; 2011.
63. YAŞAR T. What’s New in Glaucoma Surgery. Glaucoma-Cataract.
2011;6(2):069-073.
64. Radcliffe NM. Evolutions and Revolutions in Surgical Energy. Glaucoma
Today. Published 2011.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 8
65. Rosentreter A, Schild a M, Jordan JF, Krieglstein GK, Dietlein TS. A
prospective randomised trial of trabeculectomy using mitomycin C vs an
ologen implant in open angle glaucoma. Eye (Lond).
2010;24(9):1449-1457. (SCI/SCIE)
66. Rosentreter A, Mellein AC, Konen WW, Dietlein TS. Capsule excision and
OlogenTM implantation for revision after glaucoma drainage device surgery.
Graefe’s Arch Clin Exp Ophthalmol. 2010;248(9):1319-1324.
67. Boey P-Y, Narayanaswamy A, Zheng C, et al. Imaging of blebs after
phacotrabeculectomy with Ologen collagen matrix implants. Br J
Ophthalmol. 2011;95(3):340-344. (SCI/SCIE)*
68. Costin D, Constantin C, Bucatariu MP, Mousa A al, Moraru AD. Combined
mechanism glaucoma asociated with Grave ’ s Ophtalmopathy. Case report.
Rom Neurosurg. 2010;XVII(3):364-373.
69. Nilforushan N, Yadgari M, Falavarjani KG, Afshar AE. Evaluation of
Subconjunctival Oculusgen Implantation as an Adjunct to Trabeculectomy.
Iran J Ophthalmol. 2010;22(2):55-62.
70. Sarkisian SR. A Replacement for Antimetabolites? Ologen is a new product
that modulates wound healing in glaucoma surgery. Glaucoma Today.
2010.
71. Papaconstantinou D, Georgalas I, Karmiris E, et al. Trabeculectomy with
OloGen versus trabeculectomy for the treatment of glaucoma: A pilot
study*. Acta Ophthalmol. 2010;88(1):80-85.
72. Anguelov B. Trabeculectomy with absorbable suture of the scleral flap and
subconjunctival biodegradable collagen matrix implant (ologenTM) in
primary open angle glaucoma. Ref Bul Ophthalmol. 2010;1:21-28.
73. Hong SJ, Lee JR, Choi JY, Choi JW, Kim YD. Trabeculectomy With
Biodegradable Collagen Material: A Report of Two Cases. J Korean
Ophthalmol Soc |. 2010;52(6):912-918.
74. Hong S, Lee JR, Kim Y-D, Choi JY, Choi J. Fibrous Encapsulation of
Biodegradable Collagen Matrix After Trabeculectomy: A Case Report. J
Korean Ophthalmol Soc. 2010;51(4):631-635.
75. Rao K, Ahmed I, Blake D a, Ayyala RS. New devices in glaucoma surgery.
Expert Rev Ophthalmol. 2009;4(5):491-504. (SCI/SCIE)#
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 9
76. Anguelov B. Phacotrabeculectomy with absorbable suture of the scleral flap
and subconjunctival biodegradable collagen matrix implant (ologenTM) in
eyes with a cataract and primary open angle glaucoma. Ref Bul Ophthalmol.
2009;6:17-26.
77. Anguelov B. Trabeculectomy with absorbable suture of the scleral flap and
subconjunctival biodegradable collagen matrix implant (ologenTM) in
refractory glaucoma. Ref Bul Ophthalmol. 2009;5:23-30.
78. Aptel F, Dumas S, Denis P. Ultrasound biomicroscopy and optical coherence
tomography imaging of filtering blebs after deep sclerectomy with new
collagen implant. Eur J Ophthalmol. 2009;19(2):223-230. (SCI/SCIE)*
79. Dietlein TS, Jordan J, Lueke C, Krieglstein GK. Modern concepts in
antiglaucomatous implant surgery. Graefe’s Arch Clin Exp Ophthalmol.
2008;246(12):1653-1664.
80. 陈秀萍, 袁非, 陈旭, 马晓萍, 黎蕾. 胶原蛋白基质在非穿透性小梁切除术中的应用.
中国临床医学. 2008;15(No. 5):705-707.
81. Dietlein TS, Jordan J, Lueke C, Krieglstein GK. Modern concepts in
antiglaucomatous implant surgery. Graefe’s Arch Clin Exp Ophthalmol.
2008;246(12):1653-1664.
82. Zelefsky JR, Hsu W, Ritch R. Biodegradable collagen matrix implant for
trabeculectomy. Expert Rev Ophthalmol. 2008;3(6):613-617. (SCI/SCIE)
83. Kohlhaas M. Postoperative Risks in Previously Operated Eyes are Lowered.
Trabeculectomy With mitomycin C and ologenTM Implant. Ophthalmol
Nachrichten. 2008.
84. Hsu WC, Ritch R, Krupin T, Chen HSL. Tissue bioengineering for surgical
bleb defects: An animal study. Graefe’s Arch Clin Exp Ophthalmol.
2008;246(5):709-717.
85. Tope A, Mermoud A, Shaarawy J. Glaucoma 2007. Ophthalmol Times
Eur.:33-39.
86. Ritch R. Using Bioengineered Collagen Matrix During
Trabeculectomy-Biodegradable polymer implants show promise for
improving the function of filtering blebs. Glaucoma Today. 2007.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 10
Footnotes:
* OculusGenTM used in the study is the prototype brand name and has
been renamed into ologen® Collagen Matrix in July 2007 with enhanced
biocompatibility, longer biodegradation time in accordance with the wound
healing process, and more pressure sustainability and resistance to
humidity. “ologen® Collagen Matrix” has also improved for better
performance and efficacy in terms of IOP control and overall surgical
outcomes, which can be shown in the preliminary meta-analysis based on
the SCI publications available to date. The meta-analysis publications will
be reviewed and published some time in the future.
# In this review, all the references cited under Oculusgen collagen implant
were originally referred to ologen® Collagen Matrix.
(B). Scientific program (content available upon request)
1. The congress of the European Society of Ophthalmology(SOE), June 6 – 9,
2015, Vienna.
Aleksandra Wlaź, Agnieszka Wilkos-Kuc, Agnieszka Rozegnał-Madej,
Tomasz Żarnowski; Evaluation of the efficacy of colagen matrix
implants (Ologen® ) in comparison with mitomycin C for intraocular
pressure reduction in phacotrabeculectomy
2. The 119th JOS(日本眼科学会总会), April 16-19, 2015 in Sapporo, Japan
千照会・千原眼科 千原悦夫、林 妍;多孔性インプラント Ologen を用いた
緑内障手術の成績
3. The 5th International Forum of Ophthalmic Surgery; 2015, Katowice,
Poland
A. Bakunowicz-Lazarczyk, B. Urban: Ologen insertion in
trabeculectomy in children-preliminary report.
4. The 4th Asia Cornea Society Scientific Meeting(ACS), Dec. 11 – 12 2014,
Nov4-7, 2014 Taipei, Taiwan.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 11
KoHua Chen: Fish scale collagen as feeder layer for corneal
endothelial cell-sheet preparation.
5. The 2014 American Academy of Ophthalmology(AAO); Oct. 18-21,
Chicago, U.S.A.
S. Sarkisian: Preventing scarring in Glaucoma Filtration Surgery.
S. Vold: Micro invasive Glaucoma Surgery into Clinical Practice.
6. The 2014 World Ophthalmology Congress; Apr 2-5, 2014, Tokyo, Japan.
ologen® Collagen Matrix And Wound Healing Modulation In Eye Surgery.
Hall D5, Tokyo Intl Forum on Apr 3, 2014. Moderator: Robert Ritch
Angelo Tanna: An RCT in USA: ologen® Collagen Matrix vs. MMC in
Trabeculectomy- The One-Year Interim Results
Salvatore Cillino: ologen® Collagen Matrix vs. MMC in Trabeculectomy- A
Five-Year Update
Steven Sarkisian: Collagen Matrix Implant As A Wound Modulator in
Trabeculectomy With The Ex-PRESSTM Mini Glaucoma Device
Zaher Sbeity: Bleb Revision Surgery and ologen® Collagen Matrix
Kyoung Yul Seo: The Repair of Scleral Thinning With ologen® Collagen
Matrix
7. The 2013 World Glaucoma Congress; Jul 18-20, 2013, Vancouver, Canada.
New Horizons: Novel Applications for ologen Collagen Matrix. Room 202 &
203 on Jul 18. Moderator and audience response: D Godfrey.
D Godfrey: ologen Collagen Matrix: the US experience
S Vold: the Ex-Press ologen technique
R Fellman: painful bleb? Revision surgery and ologen CM.
N Hasanova: case report: ologen CM in congenital glaucoma
M Moussalli: keys to Success with logen CM in trabeculectomy and
NPDS
8. The 2013 APAO-AIOS Congress; Jan 17-20, 2013, Hyderabad, India.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 12
Breakfast Debate: “ologen Collagen Matrix or MMC for Glaucoma Surgery?
(GL-SP01)” Hall 9 on Jan 18. Moderator and audience response: R Ritch.
L Vijaya, B S Rao (MMC vs. ologen). Fundamental wound modulation
methodology and significance in clinical outcomes: bleb morphology,
complications, revision.
Sathyan P, S Sirisha (ologen vs. MMC). Safety and efficacy in
randomized controlled trials and enabling surgical tips.
R Ritch. The Use of ologen in Filtration Surgery (GL-SS08).
9. The 2012 EGS Congress; Jun 17-22, 2012, Copenhagen, Denmark. Room
Harlekin on June 19.
H J Schuitmaker. Overview of ologen® Collagen Matrix.
T S Dietlein. ologen® for surgical treatment of exposed tubes after
GDD surgery.
10. The 16th AFRO Asian Congress of Ophthalmology; Jun 13-16, 2012,
Istanbul. Ağustos Zafer Hall. Session: GLAUCOMA (CRS5) on June 13.
Tharwat Mokbel. Trabeculectomy with ologen.
11. The 2012 APAO/SOE Joint Meeting; April 13-16, 2012, Busan, Korea.
Booth 807
S B, Lee. ologen Collagen Matrix in repair of sclera thinning.
A, Rakib. ologen Collagen Matrix in pterygium excision.
J H, Son. ologen Collagen Matrix in oculoplastic surgery (DCR &
socket reconstruction etc).
S Noman. ologen Collagen Matrix in trabeculectomy (complicated
and secondary glaucoma cases).
12. The 2012 World Ophthalmology Congress (WOC); Feb 16- 20, 2012, Abu
Dhabi, United Arab Emirates.
Symposium: A Replacement for MMC? Expo Theatre.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 13
R. Ritch. Novelty design of ologen® Collagen Matrix to improve
surgical success rate without MMC.
S. Cillino. A 2-year randomized study of ologen® Collagen Matrix vs
MMC.
S. Sarkisian. Recent advances in glaucoma surgery - Clinical
experiences of ologen® Collagen Matrix in over 1000 ocular surgeries.
Z. Sbeity. ologen® Collagen Matrix in revision of filtering surgery.
P. Sathyan. Experiences & practical tips of ologen® Collagen Matrix in
Indians.
S. Rao. ologen® Collagen Matrix in developing countries – A
replacement for MMC?
Scientific Programs:
Z. Sbeity. ologen® Collagen Matrix in revision filtering surgery: is it
useful? IS-GLA-TH 28 Hall 11. Symposium on “Advanced” by MEAGS.
S. Sarkisian. ologen® Collagen Matrix implant. IS-GLA-FR 57 Hall 11.
Symposium on “Recent Advances in Glaucoma Surgery” by WGA.
P. Sathyan. Changing Trends in Trabeculectomy Video Assisted Skill
Transfer Course. CO-GLA-SA 200 Capital Suite 4. Instruction Course:
Glaucoma.
S. Wisam. Efficacy of ologen matrix implant in Jordan. IS-GLA-SU
253 Hall 11. Symposium on “Managing Glaucoma in Developing
Countries” by Ophthalmological Society of Pakistan (OSP).
Khalil Errais. Pterygium Surgery: How to Avoid Recurrence.
IS-VID-MO 351 Hall 12. Symposium on “Cornea and Ocular Surface
Diseases”
13. The 2011 World Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011, Paris.
J. Lin. Can MMC be replaced: Collagen matrix for eye tissue repair. R
341. Introduction of ologen® Collagen Matrix.
S. Cillino. Can MMC be replaced: Collagen matrix for eye tissue repair.
R 341. Biodegradable collagen matrix implant vs. mitomycin-C as an
adjuvant in trabeculectomy: A two-year randomized clinical trial.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 14
J. Lai. Can MMC be replaced: Collagen matrix for eye tissue repair. R
341. Trabeculectomy with ologen® and MMC.
P. Sathyan. Can MMC be replaced: Collagen matrix for eye tissue
repair. R 341. Trab with ologen® : The practical tips for the better
outcome and the Indian experience.
14. The 2010 World Ophthalmology Congress (WOC); June 5-9, 2010, Berlin.
Kohlhaas M. Can MMC be replaced: ologen® for eye tissue repair. H9.
500 experiences with ologen® collagen matrix in trabeculectomy.
Ni J. Can MMC be replaced: ologen® for eye tissue repair. H9.
Introduction of ologen®
Campos EC. Can MMC be replaced: ologen® for eye tissue repair. H9.
Use of ologen® collagen matrix in strabismus surgery
15. The 5th International Congress on Glaucoma Surgery (ICGS); November
11-13, 2010, New Delhi, India.
Rao BS. Plenary Session 1-Trabeculectomy: The state of the art.
PL1.5: Improving success of trabeculectomy.
Sharmila R. Plenary session 6-Wound Healing: The eye under control.
PL6.5: Trabeculectomy with subconjunctival biodegradable implant
(ologen) for the treatment of glaucoma.
Singh K. Plenary session 6-Wound Healing: The eye under control.
PL6.7: Collagen implant in trabeculectomy: our experience.
Kusumesh R. Plenary session 6-Wound Healing: The eye under
control. PL6.8: Outcome of trabeculectomy with combined use of
subconjunctival collagen implant and mitomycin c.
Aung T. Plenary Session 9-New Surgical Options: Looking ahead.
PL9.6: ologen implants for Phacotrabeculectomy.
Ariga M, Crowston J. Instruction Course 10 (basic)-Wound healing:
Practical considerations.
16. The 2008 ASCRS-ASOA Symposium and Congress; April 4-9, 2008,
Chicago, USA.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 15
Grewal SPS, Jain R, Grewal D, Brar GS. Safety and Efficacy of
OculusGen** Biodegradable Collagen Matrix Implant in
Phacotrabeculectomy Surgery.
(C). Conference papers and presentations (2008-present)
Biocornea
1. KoHua Chen, The preparation scale collagen as feeder layer for corneal
endothelial cell-sheet for DSAEK graft. 4th Asia Cornea Society Scientific
Meeting(ACS), Dec. 11 – 12 2014, Taipei, Taiwan.
2. KoHua Chen, The preparation scale collagen as feeder layer for corneal
endothelial cell-sheet for DSAEK graft. 7th World Congress on Preventive
and Regenerative Medicine (WCPRM),Nov4-7, 2014 Taipei, Taiwan.
3. Van Essen TH, Lin CC, Lai HJ, Hussain AK, Jager MJ, Luyten GPM. A
Biocornea Of Fish Scales - First Results Of A Research Model. 6038/D859
ARVO annual meeting; May 6-10, 2012, Ft. Lauderdale, USA.
4. Hos D, Bock F, Regenfuss B, Onderka J, Lin CC, Lai HJ, Cursiefen C.
Reduced Hem- And Lymphangiogenesis Into A Fishscale-derived Collagen
Scaffold Used As Biological Artificial Cornea (BioCornea). 040/D861. ARVO
annual meeting; May 6-10, 2012, Ft. Lauderdale, USA.
5. Julio Lin. Biocornea: Fish scale as a scaffold for corneal regeneration.
2012 WOC; Feb 16- 20, 2012, Abu Dhabi, United Arab Emirates.
6. Lin CC, Ritch R, Lin SM, Ni MH, Chang YC, Lin FH. Biocornea: A New Fish
Scale-derived Scaffold for Corneal Regeneration. The 25th APAO-AAO Joint
Congress; September 16-20, 2010, Beijing, China.
7. Lin CC, Ritch R, Lin SM, Ni MH, Chang YC, Lai HJ, Lin FH. The ARVO 2010
Annual Meeting; May 2-6, 2010, Fort Lauderdale, USA.
8. Van Essen TH, Lin CC, Lai HJ, Hussain AK, Luyten GPM, Jager MJ. A
biocornea of fish scale- evaluation of a research model. PNO 4088,
Association for Research in Vision and Ophthalmology annual meeting;
May 1 – 5, 2011, Fort Lauderdale, USA.
ologen® Collagen Matrix
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 16
1. N. M-H Azerbaijan, E. Kasimov, J. Hasanov. Combined trabeculotomy:
trabeculectomy with collagen matrix implant in secondary childhood
glaucoma. The European Society of Cataract and Refractive
Surgery(ESCRS); 2014, Sep 13-17, London, UK
2. Henry Chen. Follow-up for Trabeculectomy with Biodegradable 3D porous
Collagen-GlycosaminoglycanMatrix (ologen) for Treatment of High
Myopic Glaucoma. APGC-ISOHK 2014; Sep. 26-28, Hong Kong.
3. Nafees Baig, Nancy SY Yuen, Clement CY Tham. A prospective randomized
controlled trial comparing non-penetrating deep sclerectomy and
mitomycin-C with or without Ologen implant – 1-year follow-up results.
APGC-ISOHK 2014, Sep. 26-28, Hong Kong.
4. Sangchul Yoon, Ji Min Ahn, Kyoung Yul Seo_Safety and Effectiveness of
Biodegradable Implant (ologen® ) with Conjunctival Sliding Flap Surgery
for Calcified Scleromalacia. ARVO 2014. Oct. 7 - 10, Fort Lauderdale,
Florida. Asia-AR.
5. Tran Anh Tuan, Trinh Bach Tuyet, Bui Thi Thu Huong, To Ky Anh, Nguyen
Hoang Phuc. Trabeculectomy with Ologen™ (OLO) versus trabeculectomy
with mitomycin - C (MMC) for the treatment of glaucoma: a 6-month,
randomized clinical trial. The AOS 2014, July 9-11, Bangkok.
6. Dewang Angmo. P3165 Outcomes of Combined subconjunctival with
subscleral Ologen implant in glaucoma filtering surgery. The ARVO 2014;
MAY 4 - 8, 2014, ORLANDO, FLORIDA.
7. Yasser Hamed. PO620 Biodegradable Collagen Matrix (Ologen) with Low
Dose Mitomycin C in High Risk Cases and Post Failed Trabeculectomy. The
2014 WOC; Apr 2-5, Tokyo.
8. Fidan Aghayev. P0658 Trabeculectomy with Ologen® Collagen Implant vs
Trabeculectomy with Mitomycin C and Cohesive Viscoelastic in Steroid
Induced Glaucoma. The 2014 WOC; Apr 2-5, Tokyo.
9. Nigar Hasanova. VI-75 Combined Trabeculotomy with Trabeculectomy
with Subconjunctival Collagen Matrix Implant in Child with Ched and
Glaucoma. The 2014 WOC; Apr 2-5, Tokyo.
10. Babak Eliassi-Rad. PO678 Use of Collagen Matrix (Ologen) as an Adjunct
with Trabeculectomy or Phacotrabeculectomy. The 2014 WOC; Apr 2-5.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 17
11. Yuan Fei. PO286 The Efficacy and Safety of the Oculusgen (ologen)
Collagen Matrix Implanted During Surgical Excision of Primary Pterygium.
The 2014 WOC; Apr 2-5, Tokyo.
12. Momen Hamdi. PO538 Collagen Matrix Implant (Ologen) in Glaucoma
Surgeries; Precautions for a Better Control of Intraocular Pressure. The
2014 WOC; Apr 2-5, Tokyo.
13. Momen Hamdi. PO703 Trabeculectomy with Collagen Matrix Implant
(Ologen) in Primary Congenital Glaucoma. The 2014 WOC; Apr 2-5,
Tokyo.
14. John Stevens. P16 Collagen Matrix (Ologen) as a Patch Graft in Glaucoma
Tube Shunt Surgery. The 2014 AGS; Feb 27-Mar 1, Washington DC.
15. Oluwatosin Smith, David Godfrey, Davinder Grover, Michelle Butler,
Ronald Fellman. P40 Surgical Outcomes Following the Use of a
Biodegradable Subconjunctival Collagen-Glycosaminoglycan Matrix in
Revisions of Late-Onset Glaucoma Filtering Bleb Leaks. The 2014 AGS;
Feb 27-Mar 1, Washington DC.
16. D. Angmo, S. Temkar, T. Dada. P81 Outcomes of combined
subconjunctival with subscleral Ologen implant in glaucoma filtering
surgery. ICGS 2014; February 20-22, 2014, Singapore.
17. L. Pelosini, E. Ansari. P92 Trabeculectomy revision with Ologen implant.
ICGS 2014; February 20-22, 2014, Singapore.
18. M. Moussalli. P93 Keys to success when using ologen in glaucoma
surgery: trabeculectomy and non penetrating deep sclerectomy. ICGS
2014; February 20-22, 2014, Singapore.
19. Nigar Hasanova, Jamil Hasonov. PA054 Comparative Evaluation of
Combined Trabeculotomy-Trabeculectomy vs. Combined
Trabeculotomy-Trabeculectomy With Subconjunctival Implantation of
Collagen Matrix Implant for Primary Congenital Glaucoma. The 2013 AAO;
Nov 16-19, New Orleans, USA.
20. Sangchul Yoon, Kyoung Yul Seo. P116 Biodegradable implant for tissue
repair for scleromalacia treatment. The 2013 Annual Meeting of the
Korean Ophthalmological Society (KOS), Nov 1-3, Seoul, Korea.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 18
21. Eun Young Cho, Sang-Bumm Lee. P277 Novel Surgical Therapy Using
Biodegradable Collagen Matrix for Ocular Surface Reconstruction of
Scleral Thinning after Pterygium Excision. The 2013 KOS, Nov 1-3, Korea.
22. N. Baig, N. Yuen. P300 A Pilot Study of the Use of ologen in
Nonpenetrating Deep sclerectomy with MMC. The 2013 WGC; JuL 18-20,
Vancouver, Canada.
23. N. Hasanova, J. Hasanov, E. Qasimov. P336 Evaluation of Subconjunctival
Collagen Matrix Implant as An Adjunct to Combined Trabeculotomy-
Trabeculectomy in Congenital Glaucoma. The 2013 WGC; JuL 18-20,
Vancouver, Canada.
24. S. Noman. P391 Filtration Surgery – Trabeculectomy Vesus
Trabeculectomy With ologen for the Treatment of Glaucoma: A Pilot Study.
The 2013 WGC; JuL 18-20, Vancouver, Canada.
25. D. Pal, S. Chakraborty, J. Sengupta, R. Choudhary, A. Ganguly. P399
Preliminary Result of Trabeculectomy with Biodegradable Collagen Matrix
Implant in Pseudophakic Glaucoma with Myopia. The 2013 WGC; JuL
18-20, Vancouver, Canada.
26. J.H. Yim, J.H. An, H.J Cha, J.K Min. P449 Efficacy of MMC Soaked
Biodegradable Collagen Matrix Implant as A Wound Healing Modulator in
Trabeculectomy. The 2013 WGC; JuL 18-20, Vancouver, Canada.
27. Hamdi M. EP-GLA-310 Trabeculectomy with collagen matrix implant
(Ologen) in primary congenital glaucoma. The 2013 EGS Meeting; June
7-11, Copenhagen, Denmark.
28. Hamdi M. EP-GLA-311 Collagen matrix implant (Ologen) in glaucoma
surgeries; precautions for a better control of intraocular pressure. The
2013 EGS Meeting; June 7-11, Copenhagen, Denmark.
29. Marey H, Mandour S, Ellakwa A. EP-GLA-385 Subscleral trabeculectomy
with mitomycin-C versus ologen for treatment of glaucoma. The 2013 EGS
Meeting; June 7-11, Copenhagen, Denmark.
30. Dipanjan Pal, Jayangshu Sengupta. Preliminary result of trabeculectomy
with biodegradable implant in pseudophakic glaucoma with myopia. The
2013 ASCRS-ASOA Meeting; Apr 20-23, 2013, San Francisco, USA.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 19
31. Shrikant Waikar, VK Srisvstava. Management of recurrent symblepharon
with pterygium using collagen matrix scaffold implant with autologous
limbal stem cell graft. EP-0351, The 2013 APAO-AIOS Congress; Jan
17-20, 2013, Hyderabad, India.
32. Shilpa N. One year outcome of trabeculectomy with ologen. EP-0540, The
2013 APAO-AIOS Congress; Jan 17-20, 2013, Hyderabad, India.
33. Shivali M, Robert LS, Ayman N, Michel RR, Ying H. Outcomes With the
Ex-PRESS Mini Shunt Using Mitomycin C, ologen With 5-FU, and ologen
Alone. The 2012 AAO/APAO Joint Meeting; Nov 10-13, 2012, Chicago,
USA.
34. Bordeianu C. Medium-term results after trabeculectomy on scarred
conjunctiva, using fibrogenesis modulators (ologen) and fibrogenesis
inhibitors (5-FU). The XXX Congress of ESCRS; September 7-12, 2012,
Milan, Italy.
35. Hamed Y. Biodegradable collagen matrix (ologen) with low dose
mitomycin-C in bleb revision cases post failed trabeculectomy. The XXX
Congress of ESCRS; September 7-12, 2012, Milan, Italy.
36. M. Siddig. Collagen matrix implant for treatment of refractory glaucoma
(ologen) in 25 pt in Sudan. P45. The 6th ICGS; Sept 13-15, 2012, Glasgow,
UK.
37. L. Pelosini, E. Ansari. Ologen biodegradable collagen matrix implant for
trabeculectomy revision surgery: a pilot trial. P78. The 6th ICGS; Sept
13-15, 2012, Glasgow, UK.
38. Dietlein TS, Rosentreter A. Secondary subconjunctival implantation of
biodegradable porous collagen matrix for treating ocular hypotony
following trabeculectomy with mitomycin C. P 5.10 2012 EGS Congress;
Jun 17-22, Copenhagen, Denmark.
39. Kouros P, Loesche C C, Sbeity Z, Palmiero PM. ologen implants as an
adjuvant for revision surgery after failed trabeculectomy. P 5.22 2012
EGS Congress; Jun 17-22, Copenhagen, Denmark.
40. Matthew S J, Sarkisian S, Nathan B, James M R. Initial experience using a
collagen matrix implant (ologen) as a wound modulator with canaloplasty:
12 month results. 203 Glaucoma: surgery or wound healing – GL. 2012
ARVO; May 6-10, Ft. Lauderdale, USA.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 20
41. Rosentreter A, Konen W, Dietlein TS, Hermann M. Histopathologic findings
in explanted ologen Implants. 203 Glaucoma: surgery or wound healing –
GL. 2012 ARVO; May 6-10, Ft. Lauderdale, USA.
42. Wisam S. The Outcome of Trabeculectomy Using a Collagen Matrix
Implant. FP-GLA-MO 397 Free Paper: Glaucoma. The 2012 WOC; Feb 16-
20, 2012, Abu Dhabi, UAE.
43. Sathyan P. Type I collagen matrix (ologen) implant with trabeculectomy-
control 2 chambers with one sponge. VI-GLA-10 Video Presentations:
Glaucoma. The 2012 WOC; Feb 16- 20, 2012, Abu Dhabi, UAE.
44. Shobaki A. Deep sclerectomy with ologen implant. VI-GLA-15 Video
Presentations: Glaucoma. The 2012 WOC; Feb 16- 20, 2012, UAE.
45. Walimbe T. Combined small incision cataract surgery with trabeculectomy
with ologen implant. VI-GLA-24 Video Presentations: Glaucoma. The 2012
WOC; Feb 16- 20, 2012, Abu Dhabi, UAE.
46. Maragatham K. ologen implant in primary trabeculectomy. Hall D. 59th
Annual Conference of the Tamil Nadu Ophthalmic Association. Aug 05 –
Aug-07 2011, Tamil Nadu, India.
47. Alagatta SD, Sasi Kumar R, Rao D, Shetty B. Safety and efficacy of
ologenTM implant and adjunctive mitomycin C in trabeculectomy in Asian
Indian eyes with advanced glaucoma. P567. The 2011 World Glaucoma
Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.
48. Shihadeh W, Alwattar B. The outcome of trabeculectomy using a collagen
matrix implant (ologen). P569. The 2011 World Glaucoma Congress
(WGC); Jun 29 – Jul 2, 2011, Paris, France.
49. Chen HS, Hsu W. Three-year Follow-up of Trabeculectomy with
Biodegradable 3D Porous Collagen-Glycosaminoglycan Scaffold for
Treatment of Refractory Glaucoma. P634. The 2011 World Glaucoma
Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.
50. Kee MJ, Ho YJ, Changwon K. Clinical experience of mytomycin-C soaked
collagen matrix implant in trabeculectomy. P636. The 2011 World
Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 21
51. Wiyogo WA. Trabeculectomy using biodegradable collagen matrix implant
in chronic primary glaucoma patients. P644. The 2011 World Glaucoma
Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.
52. Ali SI. Study of the safety and effectiveness between ologenTM collagen
matrix implant and mytomycin-C in standard glaucoma filtration surgery.
P648. The 2011 World Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011,
Paris, France.
53. Ezpeleta Campana J A, Muniesa Royo M J, Jurjo Campo C, Traveset Maeso
A, Sanchez Perez C. Effectiveness of the Ex-Press Mini Glaucoma Shunt in
the Treatment of Primary Open-Angle Glaucoma. P697. The 2011 World
Glaucoma Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.
54. Kirilova Y, Hergeldzhieva-Fileva T, Vassileva P. Control of Intraocular
Pressure in Secondary Glaucoma. GS8. The 2011 World Glaucoma
Congress (WGC); Jun 29 – Jul 2, 2011, Paris, France.
55. Rosentreter A, Schild AM, Gaki S, Mellein AC, Dietlein TS. The ARVO 2011
Annual Meeting; May 1-5, 2011, Fort Lauderdale, USA.
56. Rouse JM, Sarkisian SR. Trabeculectomy Using Collagen Matrix Implant: A
retrospective Review on 1-Year Data. AGS, 21st Annual Meeting; March
3-6, 2011, Dana Point, California, USA.
57. Rao BS. Ologen as an adjunct in refractory glaucoma surgery. The 25th
APAO-AAO Joint Congress; September 16-20, 2010, Beijing, China.
58. Tzvetkova B, Anguelov B. The 9th Congress of the EGS; September 12-17,
2010, Madrid, Spain.
59. Jin Ho Y, Chul Min K, Changwon K. The 9th Congress of the EGS;
September 12-17, 2010, Madrid, Spain.
60. Rosentreter A, Mellein AC, Konen WW, Dietlein TS. P-TU-066 Capsule
Excision and ologen Implantation for Revision After Glaucoma Drainage
Device Surgery. WOC 2010; June 5-9, Berlin, Germany.
61. Rosentreter A, Schild AM, Jordan JF, Krieglstein GK, Dietlein TS. A
Prospective Randomized Trial of Trabeculectomy Using Mitomycin C vs. an
Ologen Implant in Open Angle Glaucoma. The ARVO 2010 Annual Meeting;
May 2-6, 2010, Fort Lauderdale, USA.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 22
62. Htoon HM, Boey P-Y, Narayanaswamy A, Zheng C, Perera SA, Wong TT,
Aung T. Imagining of Blebs After Phacotrabeculectomy With Ologen
Collagen Matrix Implants. The ARVO 2010 Annual Meeting; May 2-6, 2010,
Fort Lauderdale, USA.
63. Chen HSL, Hsu WC. Trabeculectomy With Biodegradable Porous
Collagen-Glycosaminoglycan Matrix Implant for Treatment of Refractory
Glaucoma. AAO-PAAO Joint Meeting; Oct 24-27, 2009, San Francisco,
USA.
64. Ogle J, Lim BA. 12.8.5 Surgical Treatment: Filtering surgery: Other. WGC
2009; July 8-11, 2009, Boston, USA.
65. Sumantri W. 12.8.10 Surgical Treatment: Filtering surgery:
wound-healing antifibrosis. WGC 2009; July 8-11, 2009, Boston, USA.
66. Narayanaswamy KA, Seah SK, Perera SA, Wong TT, Hoh ST, Aung T.
12.14.3 Surgical Treatment: Combined cataract extraction and glaucoma
surgery: Phacoemulsification. WGC 2009; July 8-11, 2009, Boston, USA.
67. Chen HS-L, Hsu W-C. 12.8.2 Surgical Treatment: Filtering surgery: With
tube implant or other drainage devices. WGC 2009; July 8-11, 2009,
Boston, USA.
68. Chen H. EH2-352 Trabeculectomy With Biodegradable 3D Porous
Collagen-Glycosaminoglycan Scaffold for Treatment of Refractory
Glaucoma. The 24th APAO-AAO Joint Congress; May 16-19, 2009, Bali,
Indonesia.
69. Prihatningtias R, Sadasih W, Rahmi F. EN1-039 The Comparison Between
ologen Collagen Matrix Implant & Mitomycin-C in the Glaucoma Filtration
Surgery. The 24th APAO-AAO Joint Congress; May 16-19, 2009, Bali,
Indonesia.
70. Sadasih W. EN1-043 The Comparison Between ologen Collagen Matrix
Implant & Mitomycin-C in the Glaucoma Filtration Surgery. The 24th
APAO-AAO Joint Congress; May 16-19, 2009, Bali, Indonesia.
71. Ali I, Butt N. EN2-027 Study of the Safety and Effectiveness Between
Collagen Matrix Implant and Mitomycin-C in Standard Glaucoma Filtration
Surgery. The 24th APAO-AAO Joint Congress; May 16-19, 2009, Bali,
Indonesia.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 23
72. Shihadeh W A. Efficacy and Safety of Utilizing a Biodegradable Collagen
Matrix Implant in Trabeculectomy. MEACO; March 26-30, 2009, Manama,
Bahrain.
73. Wu Q, Du X, Song B. SP058 Trabeculectomy With ologen Collagen Matrix
Implant: the Treatment Outcomes After Six Month of Follow-up. The 5th
Congress of SEAGIG; September 25-27, 2008, Seoul, Korea.
74. Singh K, Khurana C. SF017 Bleb Characteristics of Subconjunctival
Collagen Implant in Trabeculectomy Compared With Mitomycin Blebs. The
5th Congress of SEAGIG; September 25-27, 2008, Seoul, Korea.
75. Kohlhaas M. DO.16.04 Trabeculectomy With Mitomycin C and ologen. The
106th DOG Congress; September 18-21, 2008, Berlin, Germany.
76. Ozcan AA, Dulger E, Simsek F. Ex-PRESS R-50 Miniature Glaucoma
Implant Insertion Under the Sclera Combined With Mitomycin C and
OculusGen** Application. The XXVI Annual Congress of ESCRS;
September 13-17, 2008, Berlin, Germany.
77. Shihadeh W. Efficacy and Safety of Utilizing A Biodegradable Collagen
Matrix Implant in Trabeculectomy. The XXVI Annual Congress of ESCRS;
September 13-17, 2008, Berlin, Germany.
78. Yuan F, Li L, Chen X, Wang L. Biodegradable 3D-Porous
Collagen-Glycosaminoglycan Scaffold for Treatment of Refractory
Glaucoma. WOC 2008; June 28-July 2, 2008, Hong Kong.
79. Lim BA, Ogle J. GC-D1-166 The Use of Biodegradable Collagen Implant in
Trabeculectomy. WOC 2008; June 28-July 2, 2008, Hong Kong.
80. Grewal SPS, Grewal D, Jain R, Brar GS. GC-D1-188 Adjunct Use of
Biodegradable Porous Collagen-Glycosaminoglycan Implant in
Phacoemulsification Combined With Trabeculectomy for Surgical
Management of Primary Open Angle Glaucoma. WOC 2008; June 28-July 2,
2008, Hong Kong.
81. Kaljurand K. GC-D3-133 Ologen Collagen Matrix Implant in Glaucoma
Filtration Surgery. WOC 2008; June 28-July 2, 2008, Hong Kong.
82. Ali SI, Butt NH. Study of the Safety and Effectiveness Between ologen
Collagen Matrix Implant and Mitomycin-C in Standard Glaucoma Filtration
Surgery. WOC 2008; June 28-July 2, 2008, Hong Kong.
Aeon Astron Europe B.V.: Reference list, Version 46, January 2017 24
83. Jansari P, Porwal M, Hindocha C. Trabeculectomy With Subconjunctival
Biodegradable Implant. WOC 2008; June 28-July 2, 2008, Hong Kong.
Footnotes:
* Before year 2008, there are 26 ologen posters or presentations presented in
the international Conferences.
** OculusGenTM Collagen Matrix has been renamed into ologen® Collagen
Matrix in July 2007. The implants used in this study are OculusGenTM Collagen
Matrix. The material constituents and the physical properties of OculusGenTM
Collagen Matrix has been improved and upgraded for better performance and
efficacy. This becomes ologen® Collagen Matrix. Furthermore, when ologen®
Collagen Matrix is applied in trabeculectomy, loose suture on the sclera flap is
strongly recommended.
Abbreviations: AAO, American Academy of Ophthalmology; APAO,
Asia-Pacific Academy of Ophthalmology; ARVO, Association for Research in
Vision and Ophthalmology; ASCRS, American Society of Cataract and
Refractive Surgery; ASOA, American Society of Ophthalmic Administrators;
DOG, Deutsche Ophthalmologische Gesellschaft; EGS, European Glaucoma
Society; ESCRS, European Society of Cataract and Refractive Surgeons; ICGS,
International Congress on Glaucoma Surgery; MEACO, Middle East African
Council of Ophthalmology; SEAGIG, South East Asia Glaucoma Interest Group;
SOE, European Society of Ophthalmology; WGC, World Glaucoma Congress;
WOC, World Ophthalmology Congress.